IPC
NEO icon

Independent Portfolio Consultants’s NeoGenomics NEO Stock Holding History

Independent Portfolio Consultants’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$17K Buy
1,930
+740
+62% +$5.87K 0.01% 634
2017
Q1 		$9K Buy
+1,190
New +$9.69K ﹤0.01% 762

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Independent Portfolio Consultants's NEO Position: Q2 2017 in Review

Independent Portfolio Consultants increased its NeoGenomics (NEO) stake by 62% in Q2 2017, buying an estimated $5.87K and bringing the position to 1,930 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #634.

Independent Portfolio Consultants first reported a position in NEO in Q1 2017 and has held it in 2 quarters since. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

  • Independent Portfolio Consultants held 1,930 shares of NeoGenomics worth $17K as of Q2 2017.
  • Independent Portfolio Consultants bought 740 NeoGenomics shares in Q2 2017, an estimated $5.87K.
  • NeoGenomics made up 0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #634 holding.
  • Independent Portfolio Consultants first reported a position in NeoGenomics in Q1 2017 and has held it in 2 quarters since.
  • 134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.